3 completed, 3 withdrawn. 5 Phase 2, 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Withdrawn 2 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Withdrawn 1 |
Follow Sue O'Dorisio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents 177Lu-DOTA-tyr3-OCTREOTATE, Peptide Receptor Radiotherapy (PRRT) - Neuroendocrine Tumors, Pheochromocytoma | Phase 1 / Phase 2 | Withdrawn | Sue O'Dorisio | 2020-08-04 | 2021-06-08 | |
| Dosimetry Guided PRRT With 90Y-DOTATOC 90Y-DOTA-3-tyr-Octreotide, Positron Emission Tomography (PET) whole body scan, Amino Acids - Neuroendrocrine Tumors, Meningioma | Phase 2 | Withdrawn | Sue O'Dorisio | 2017-01-01 | 2017-08-25 | |
| Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors 68Ga-DOTATOC PET/CT - Neuroendocrine Tumors, Carcinoid Tumors | Phase 2 | Completed | Sue O'Dorisio | 122 | 2015-09-01 | 2020-12-21 |
| Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors gallium Ga 68-edotreotide, positron emission tomography, computed tomography - Acoustic Schwannoma, Adult Anaplastic Astrocytoma | Not applicable | Withdrawn | Sue O'Dorisio | 2013-09-01 | 2017-04-28 | |
| Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT gallium Ga 68-edotreotide, positron emission tomography/computed tomography, indium In 111 pentetreotide - Adult Medulloblastoma, Childhood Medulloblastoma | Phase 2 | Completed | Sue O'Dorisio | 68 | 2013-04-01 | 2021-09-22 |
| Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors 68Ga-DOTATOC PET/CT - Neuroendocrine Tumors, Carcinoid Tumors | Phase 1 / Phase 2 | Completed | Sue O'Dorisio | 223 | 2012-02-21 | 2021-07-27 |
Medulloblastoma (5) · Neuroblastoma (4) · Neuroendocrine Tumors (4) · Carcinoid Tumor (2) · Meningioma (2) · Astrocytoma (1) · Brain Neoplasms (1) · Choroid Plexus Neoplasms (1) · Craniopharyngioma (1) · Ependymoma (1) · Familial ependymoma (1) · Glioblastoma (1) · Glioma (1) · Glioma, Subependymal (1) · Gliosarcoma (1)
Magnetic Resonance Spectroscopy (3) · gallium Ga 68 dotatate (3) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (2) · 90Y-octreotide, DOTA-Tyr(3)- (1) · Amino Acids (1) · Whole Body Imaging (1) · arginyllysine (1) · lutetium Lu 177 dotatate (1) · pentetreotide (1)
United States (5)
M. Sue O'Dorisio, MD, PhD (2) · M S O'Dorisio, MD, PhD (1) · M. Sue O' Dorisio, MD, PhD (1) · Mary S O'Dorisio, MD, PhD (1)
P30CA086862 (2), R01CA167632 (2)